Read more: Valneva’s Chikungunya Vaccine Candidate Awarded EMA Prime Designation
Read more: Valneva’s Chikungunya Vaccine Candidate Awarded EMA Prime Designation
See the original post here: Medicenna Provides MDNA55 rGBM Clinical Program Update Following Positive End of Phase 2 Meeting with the U.S. Food and Drug Administration (FDA)
See the article here: Adaptimmune Provides Full Contents of its SITC Abstract for the Phase 1 SURPASS Trial
See the original post here: MacroGenics Announces Flotetuzumab Publication in Blood Advances
Read more from the original source: MDxHealth announces listing of 20,162,924 existing shares on Euronext Brussels following Equity Investment by MVM Partners
Follow this link: Imara Announces First Patient Dosed in Forte Phase 2b Clinical Trial of IMR-687 in Beta-Thalassemia
More: Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
Read the original here: ASLAN Pharmaceuticals to Develop ASLAN003 as Next Generation DHODH Inhibitor in Autoimmune Conditions
See more here: Cantor Fitzgerald and Kristen Kluska to Host Zoom Fireside Chat with Ocugen
See the original post: First Patient Dosed in Phase II Trial to Treat Complications in COVID-19
Recent Comments